DACIVO Injection 0.5 mg

Dacivo Injection is a medication used to combat cancer, containing Dactinomycin, which is also referred to as actinomycin D. It falls under the category of antineoplastic antibiotics, frequently utilized in chemotherapy. This drug is mainly employed to address certain cancer types by inhibiting or halting the proliferation of cancer cells. Dactinomycin is generally administered via injection, under the guidance of a qualified healthcare provider.

Dacivo Injection is applicable for various cancers, including Wilms’ tumour, rhabdomyosarcoma, Ewing’s sarcoma, and testicular cancer, among others. While it is effective, caution is advised for patients with liver problems or low blood counts. Its use is not recommended during pregnancy or breastfeeding unless absolutely necessary. Patients receiving this treatment require careful medical supervision due to potential side effects and drug interactions. Always notify your physician about any current medications or health issues prior to commencing therapy.